{PRODUCT NAME} is also indicated to reduce total-C and LDL-C in patients with homozygous familial hypercholesterolaemia as an adjunct to other lipid-lowering treatments (e. g.
La administración concomitante de 40 mg de atorvastatina y 200 mg de itraconazol diarios produjo un aumento de tres veces el ABC de atorvastatina.